business
Kodiak Stock Gains 183% as New Eye Drugs Take Aim at Regeneron’s Eylea
Kodiak Sciences plans to file for regulatory approval of one drug candidate, Zenkuda, following its success in a trial for wet age-related macular degeneration.
You are now leaving Barron's website
By clicking on the “Proceed” button below, you will be redirected to a third-party website owned and operated by Hong Kong Tiimoot Information Technology Co., Limited. (“HKT”), which is located in Hong Kong. That ... [255 chars]
Read Full ArticleShare this story
Up next
Related Stories
UK Prime Minister Burnham says Iran 'played a part' in British air base incident
cnbc.com
Piyush Goyal gets a ‘trade minister for life’ tag from US trade chief at G20
timesofindia.indiatimes.com
Trump touts $200 billion South Korean investment plan as Alaska LNG project hangs in balance
cnbc.com
Cornell rape case: Prosecutor says he wasn't given transcript of Jane Doe's interview with campus police; university agrees to independent investigation, New York governor says
yahoo.com
Passengers and crew foil co-pilot's apparent attempt to crash FlyDubai flight to Israel
cnbc.com